Effect of IV Fluid Type and Rate on Mortality in Critical Illness, Environmental Remediation for Asthma Prevention in Urban Schoolchildren, Review of Pancreatic Cancer, and more
Editor’s Summary by Michael Berkwits, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the September 7, 2021 issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - September 7, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Diabetes Core Update – November 2019
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - October 25, 2019 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts

Jack Stewart discusses SOR-C18 leading the phase 1b clinical trial in pancreatic cancer
Jack Stewart, CSO of Soricimed Biopharma explains SOR-C13 is the leading drug in a phase 1b clinical trial in late stage pancreatic cancer. Author: Cancer-News Added: 08/23/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2019 Category: Cancer & Oncology Source Type: podcasts

Jack Stewart discusses SOR-C18 potential in different cancers
Jack Stewart, CSO of Soricimed Biopharma elaborates on how SOR-C18 potentially showing promise in ovarian, metastatic prostate and pancreatic cancer. Author: Cancer-News Added: 08/23/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2019 Category: Cancer & Oncology Source Type: podcasts

Immediate Implications of the POLO study.
POLO trial for advanced pancreatic cancer: a new standard of care. Treatment with the drug olaparib significantly reduced the risk of disease progression or death from metastatic pancreatic cancer, Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Unanswered questions after the POLO study
POLO trial for advanced pancreatic cancer: a new standard of care. Treatment with the drug olaparib significantly reduced the risk of disease progression or death from metastatic pancreatic cancer, Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

USPSTF Recommendation: Screening for Pancreatic Cancer
Interview with Chyke A Doubeni, MD, MPH, USPSTF member and coauthor of Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - August 6, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts

BP Measurements and Mortality and CVD Risk, Charity Patient Assistance Programs, Lifestyle and Dementia, Screening for Pancreatic Cancer, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, for the August 06, 2019 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - August 6, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts

APACT Trial in Pancreatic Adenocarcinoma
Leonard Saltz, MD, Executive Director for Clinical Value and Sustainability, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center shares the results from the APACT study, a phase III tr... Author: obr Added: 07/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Biomarkers in the Treatment of Pancreatic Cancer
Talia Golan, MD, Head of Sheba Pancreatic Cancer Center shares the important role biomarkers have in the treatment of pancreatic cancer patients. Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts